EastBridge Partners invests $30mln in Vietnam’s USM Healthcare

USM Healthcare is the private equity firm’s third investment in Southeast Asia. The Vietnam firm plans to use the proceeds to expand production capacity and in research and development.

Vietnam still largely depends on expensive imports for its medical equipment needs and USM Healthcare wants to serve lower to middle-income patients with high quality yet affordable medical devices, stated USM Healthcare founder and CEO Boi Lam.

“We see EastBridge Partners as a partner who could help us achieve these objectives and support overseas expansion with their resources and networks in Korea, Southeast Asia, Middle East,” she added.

Meanwhile, EastBridge Partners expressed confidence in USM Healthcare’s unique position as the only coronary stent manufacturer in Vietnam as well as its strong research and development capabilities. “There is potential for the business to grow into the leading innovative medical device group in Vietnam,” said Mark Kim, Chief Investment Officer at EastBridge Partners.

Established in 2012, USM Healthcare is the first and only coronary stent developer and manufacturer in Vietnam. It produces and sells a diverse portfolio of products, including coronary stents, balloon catheters, and medical consumables.

USM Healthcare factory is well equipped with facilities to meet high-tech production requirements including production workshops, microbiology and quality control rooms, testing rooms, materials, and packing warehouses.

EastBridge Partners is a mid-market private equity firm with a presence in Seoul, Singapore, and Ho Chi Minh City. The firm’s current active AUM is over $1 billion. It invests across Korea and South East Asia, focusing on the consumer goods & services, technology, healthcare, industrial & logistics sectors.